Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

IRF9 inhibits USP18. 2 / 2

| 2

➶

reach

"Low dose IFNα increases baseline STAT2 and IRF9 expression without strongly activating the negative feedback regulators SOCS1, SOCS3, and USP18, thereby hypersensitizing cells to further interferon stimulation (26)."

35471841

➶

reach

"The same procedure was performed for CRISPR based tagging the additional genes, STAT1, IRF9 and USP18 sequentially.The knockdown of USP18 by shRNA was done using retrovirus transduction."

32945770

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...